A novel GLP-1 and FGF21 dual agonist has therapeutic potential for diabetes and non-alcoholic steatohepatitis
新型 GLP-1 和 FGF21 双重激动剂具有治疗糖尿病和非酒精性脂肪性肝炎的潜力
期刊:EBioMedicine
影响因子:9.7
doi:10.1016/j.ebiom.2020.103202
Qi Pan, Shushan Lin, Yu Li, Liang Liu, Xiaoping Li, Xianglei Gao, Jiangyu Yan, Baohua Gu, Xiaofeng Chen, Wenjia Li, Xinfa Tang, Chao Chen, Lixin Guo
